Skip to main content
. 2012 Nov 7;7(11):e49191. doi: 10.1371/journal.pone.0049191

Figure 1. Caprylic triglyceride is well tolerated and attenuated ALS-type motor impairment in SOD1-G93A mouse model.

Figure 1

(A) Average body weight in wild type (WT) animals (n = 6–7 per group); (B) Motor function as assessed by rotarod test in WT animals (n = 5–7 per group); (C) Average body weight in SOD1-G93A (ALS) animals (n = 17–18 per group); (D) Motor function as assessed by rotarod test in SOD1-G93A animals (n = 13–14 per group). Arrows indicate where the caprylic triglyceride group showed improved motor function as compared to the control by two way ANOVA analysis, F = 6.56, p = 0.01 followed by Bonferroni post-test, *p<0.05. All data are mean ± SEM.